Skip to search formSkip to main contentSkip to account menu

Zuclopenthixol dihydrochloride

Known as: (Z)-4-(3-(2-Chloro-9H-thioxanthen-9-ylidene)propyl)-1-piperazineethanol Dihydrochloride, Zuclopenthixol Hydrochloride, cis-Clopenthixol Hydrochloride 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
BACKGROUND Oral zuclopenthixol dihydrochloride (Clopixol) is an anti-psychotic treatment for people with psychotic symptoms… 
2013
2013
OBJECTIVE To evaluate the effects of medetomidine, midazolam and ketamine (MMK) in captive gorillas after premedication with oral… 
2010
2010
Objective: Prescribers are warned to be vigilant for potential cytochrome P450 mediated drug interactions; guidelines separately… 
Review
2009
Review
2009
We searched the Cochrane Schizophrenia Group’s register (December 2004). This register is compiled of methodical searches of… 
Review
2002
Review
2002
Objective: This paper illustrates the process that was undertaken in the development of guidelines for the use of Zuclopenthixol… 
2001
2001
A flow-injection (FI) methodology using tris(2,2'-dipyridyl)ruthenium(II), [Ru(dipy)3(2+)], chemiluminescence (CL) was developed… 
Highly Cited
1991
Highly Cited
1991
The pharmacokinetics of a single oral dose of the neuroleptic drug zuclopenthixol (10 or 6 mg) was studied in 6 extensive and 6… 
1989
1989
1987
1987
An assessment of the efficacy and tolerability of zuclopenthixol dihydrochloride tablets in the treatment of acute psychotic… 
1985
1985
An open, multi-centre study was carried out in 69 patients with an acute psychotic episode to assess the efficacy and side…